Herts and Essex Fertility - IVF Spot Purchase NCL ICB

The NHS North Central London Integrated Care Board (ICB) has concluded a procurement process for "Herts and Essex Fertility - IVF Spot Purchase NCL ICB" through a Provider Selection Regime (PSR) Direct Award, falling under the Health Care Services (Provider Selection Regime) Regulations 2023. The contract concerns in vitro fertilisation services with a geographic focus on the UKH2 region, specifically around Cheshunt. The procurement process, identified as a limited method due to it being an award procedure without prior publication of a call for competition, has reached the award stage with the contract being signed on 14 November 2025.

The key industry category for this procurement is health services, and the process was governed by regulations outside the scope of the Public Contracts Regulations 2015. This tender offers significant opportunities for businesses specialising in fertility services, particularly those able to operate within the healthcare framework set down by NHS regulations. As the procurement was a direct award under the Provider Selection Regime, businesses already within the network or seeking to join NHS frameworks can benefit by leveraging established relationships or demonstrating unique service delivery capabilities.

The Herts and Essex Fertility Centre, being the successful provider, highlights potential growth opportunities for service providers focusing on patient choice and those aiming to work closely with NHS bodies. This could be particularly advantageous for small and medium-sized enterprises (SMEs) within the healthcare services sector.